EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Neurocognitive Impairment in Post-COVID-19 Condition in Adults: Narrative Review of the Current Literature

William Garmoe iD, Kavitha Rao, Bethany Gorter, Rachel Kantor

Archives of Clinical Neuropsychology · 24.04.2024 · 39 (3) · 276-289

DOI: 10.1093/arclin/acae017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archives of Clinical Neuropsychology, online erschienen am 22.03.2024. Verfasst von William Garmoe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Director of Psychology, MedStar National Rehabilitation Network, Washington, DC, USA. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Post-Acute COVID-19 Syndrome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 143 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The severe acute respiratory syndrome coronavirus 2 virus has, up to the time of this article, resulted in >770 million cases of COVID-19 illness worldwide, and approximately 7 million deaths, including >1.1 million in the United States. Although defined as a respiratory virus, early in the pandemic, it became apparent that considerable numbers of people recovering from COVID-19 illness experienced persistence or new onset of multi-system health problems, including neurologic and cognitive and behavioral health concerns. Persistent multi-system health problems are defined as Post-COVID-19 Condition (PCC), Post-Acute Sequelae of COVID-19, or Long COVID. A significant number of those with PCC report cognitive problems. This paper reviews the current state of scientific knowledge on persisting cognitive symptoms in adults following COVID-19 illness. A brief history is provided of the emergence of concerns about persisting cognitive problems following COVID-19 illness and the definition of PCC. Methodologic factors that complicate clear understanding of PCC are reviewed. The review then examines research on patterns of cognitive impairment that have been found, factors that may contribute to increased risk, behavioral health variables, and interventions being used to ameliorate persisting symptoms. Finally, recommendations are made about ways neuropsychologists can improve the quality of existing research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive DysfunctionPost-Acute COVID-19 SyndromeAdultHumansCOVID-19SARS-CoV-2Neuropsychology

Stichwörter der Autor:innen

COVID-19Cognitive impairmentLong-COVIDPASCPCC

Autor:innen und Institutionen

  • Director of Psychology, MedStar National Rehabilitation Network, Washington, DC, USA.
  • Clinical Neuropsychologist, MedStar Good Samaritan Hospital, Baltimore, MD, USA.
  • Neuropsychology Post-Doctoral Fellow, MedStar National Rehabilitation Hospital, Washington, DC, USA.

ORCID-Profile: William Garmoe

Zitieren

APA

Garmoe, W., Rao, K., Gorter, B., & Kantor, R. (2024). Neurocognitive Impairment in Post-COVID-19 Condition in Adults: Narrative Review of the Current Literature. Archives of Clinical Neuropsychology, 39(3), 276-289. https://doi.org/10.1093/arclin/acae017

Vancouver

Garmoe W, Rao K, Gorter B, Kantor R. Neurocognitive Impairment in Post-COVID-19 Condition in Adults: Narrative Review of the Current Literature. Archives of Clinical Neuropsychology. 2024;39(3):276-289. doi:10.1093/arclin/acae017

BibTeX
@article{Garmoe2024,
  author = {Garmoe, William and Rao, Kavitha and Gorter, Bethany and Kantor, Rachel},
  title = {Neurocognitive Impairment in Post-COVID-19 Condition in Adults: Narrative Review of the Current Literature},
  journal = {Archives of Clinical Neuropsychology},
  year = {2024},
  volume = {39},
  number = {3},
  pages = {276--289},
  doi = {10.1093/arclin/acae017}
}
Kostenlos starten →